Tobramycin sulfate is an aminoglycoside antibiotic used for the treatment of infections caused by susceptible Gram-negative bacteria, particularly Pseudomonas aeruginosa (including gentamicin-resistant strains), Escherichia coli, Klebsiella spp., Enterobacter spp., Proteus spp. (indole-positive and indole-negative), Citrobacter spp., and Providencia spp. Its clinical applications include:
1. Moderate to severe infections due to Enterobacteriaceae and other Gram-negative bacilli;
2. Moderate to severe Pseudomonas aeruginosa infections, often in combination with antipseudomonal β-lactams or other antibiotics;
3. Adjunctive therapy (not first-line) for serious Staphylococcus or Enterococcus infections, such as Pseudomonas aeruginosa infections outside the central nervous system and sepsis, lower respiratory tract infections, intra-abdominal infections, skin and soft tissue infections, and bone infections caused by susceptible organisms.